The price of Brent crude oil is up by 0.7% to $69.26 per barrel Oil prices are up on Tuesday as investors’ hopes of a recovery in demand for fuel were boosted following the US’s drug regulator approving the Pfizer Covid-19 vaccine. The price of Brent crude oil is up by 0.7% to $69.26 per […]

The post Oil prices rise on approval of vaccine by US regulator appeared first on UK Investor Magazine.

Biden also confirmed intention to run again in 2024 Joe Biden announced in his first press conference as president that he had doubled his administration’s vaccination target to 200m during his first 100 days in office. “I know it’s ambitious, twice our original goal, but no other country in the world has even come close […]

The post Biden confirms new vaccine goal of 200m shots in first 100 days appeared first on UK Investor Magazine.

Vaccine withdrawn by Denmark, Norway and Iceland as a ‘precaution’ Denmark, Norway and Iceland have halted the Oxford/AstraZeneca vaccine after a Danish women died with blood clots after receiving a jab. The EU medicines agency stated that there is no indication the jab had caused the blood clots. AstraZeneca confirmed in a statement that the […]

The post AstraZeneca shares dive as European countries suspend use of vaccine appeared first on UK Investor Magazine.

Following a combination of the US stimulus package, positive news over vaccines and rising oil prices, the FTSE 100 began the week in a buoyant mood. The index rose by 70 points, up nearly 1%, as positive economic news broke across the world.  “After finally getting some impetus on a Friday afternoon, at a time […]

The post FTSE 100 starts off ‘without a hint of a hangover’ appeared first on UK Investor Magazine.

The vaccine aims to address various strains of Covid-19 GSK’s share price rose by 0.75% at opening on Monday upon news that the company would be developing a vaccine.  GSK and CureVac, the German pharmaceutical company, have joined forces to develop the next generation of mRNA Covid-19 vaccines. The company is targeting availability in 2022, […]

The post GSK enters collaboration to develop new vaccine appeared first on UK Investor Magazine.

As the mass Covid-19 vaccination drive continues, new data from Finaria.it has revealed that vaccine developers BioNTech-Pfizer (NASDAQ:BNTX, NYSE:PFE) and Moderna (NASDAQ:MRNA) are set to bank $14.7bn in revenue from sales of their coronavirus vaccines by 2023. The Pfizer-BioNTech candidate made headlines for becoming the first vaccine to be approved for use in the general […]

The post Vaccine developers to bank $14.7bn by 2023 appeared first on UK Investor Magazine.

Shares at American pharmaceutical firm Pfizer (NYSE:PFE) have slipped after its announcement that it will be temporary reducing deliveries of its Covid-19 vaccine to Europe while it seeks to upgrade its production capacity to the target 2 billion doses per year. “This temporary reduction will affect all European countries,” a spokeswoman for Pfizer Denmark said […]

The post Pfizer shares slide on vaccine delivery cuts appeared first on UK Investor Magazine.

Shares at British biotechnology firm Synairgen (LON:SNG) have surged more than 7% after the launch of its new large-scale Covid-19 treatment trial. The Southampton-based company treated its first patient at Hull Royal Infirmary on Tuesday afternoon, using the newly-developed formulation SNG001, which involves the inhalation of a naturally-occurring protein named interferon beta which is believed […]

The post Synairgen shares surge on trial launch appeared first on UK Investor Magazine.

Vaccines are increasingly being seen as the key to a sustained recovery for UK businesses. New research has revealed that 92% of owners of independent public-facing companies across the retail, hospitality and travel sectors believe that vaccinating British consumers is the “golden ticket” to a post-pandemic recovery, and are reportedly considering inviting back the customers […]

The post 92% of businesses say vaccines are “golden ticket” to recovery appeared first on UK Investor Magazine.

Speaking in the Commons on Monday, Health Secretary, Matt Hancock, said that the UK government had informed the WHO about a new strain of the Covid virus spreading in southeast England. Discovered by Porton Down Laboratory scientists, the new Covid strain is not currently viewed as more serious than previously-known variants. Mr Hancock added that […]

The post New Covid Strain: should we be worried? appeared first on UK Investor Magazine.

Tui (LON: TUI) has sunk to a €3bn (£2.7bn) full-year loss. The holiday operator posted a 58% slide in revenues to €7.9bn (£7.2bn) amid the pandemic and warns it does not expect to return to normal trading levels until 2022. The company is raising its cost-cutting targets to €400m per year as winter bookings this […]

The post Tui sinks to €3bn loss appeared first on UK Investor Magazine.

The FTSE 100 had a subdued start to the day despite news that the UK had approved the Pfizer/Biontech coronavirus vaccine. The blue-chip index opened in the red and after an hour was up 0.1%. Analysts have said that it is likely that because the pound is down 0.4% against the dollar and 0.5% against […]

The post FTSE 100 makes slow start despite vaccine news appeared first on UK Investor Magazine.

The FTSE 100 opened higher on Tuesday as markets continued to react well to the ongoing vaccine news. The FTSE 100 opened 55 points higher or 0.87% to 6389 in early trading, which was boosted by growth in travel stocks, energy companies and hospitality firms. In Europe, markets also opened higher. Germany’s DAX increased by […]

The post FTSE 100 opens higher on vaccine news & Biden transition appeared first on UK Investor Magazine.

Shock, the third Monday in a row where vaccine news push value stocks higher. Though underwhelming, the AstraZeneca (LON:AZN) vaccine trial results shoved long-suffering air travel, financial and commodities stocks higher, once again. Across the FTSE 100, air travel stocks led the way, with Rolls Royce soaring 7.60%, while IAG bounced around 5.50%. Meanwhile, mining […]

The post Air travel, financial and commodities stocks soar on AstraZeneca vaccine news appeared first on UK Investor Magazine.

Shares at Cambridge-based pharmaceuticals firm AstraZeneca (LON:AZN) have slid over 1% on Monday morning despite the news that their coronavirus vaccine, in collaboration with Oxford University, has proven to be up to 90% effective in interim trial data. Initial results showed the first half dose is able to provide 70% protection against the virus, but […]

The post AstraZeneca share price slides despite positive trial results appeared first on UK Investor Magazine.

The price of oil has hit its highest level since early September. As markets are optimistic around the vaccine news, the demand for oil should continue to increase if the vaccine is rolled out. Brent crude is up 1.67% at $45.71 per barrel, which is the highest price in nearly three months. “Positive sentiment continues […]

The post Oil prices: Brent Crude hits highest level since September appeared first on UK Investor Magazine.

Unsure of what to do with themselves after a mixed week, global equities posted relatively modest movements as they responded to a varied bag of news updates on vaccine updates, retail sales and US stimulus. Between Pfizer and Moderna one-upping each-other with positive news, markets have been spurred on since the booming US election week. […]

The post Global equities in mixed minds about vaccine, retail sales and US stimulus appeared first on UK Investor Magazine.

Tech and growth stock-heavy index, the Nasdaq Composite, escaped the market correction on Thursday, as virus fears crunched over-extended value equities. European equities fell sharply during the morning, with the DAX and CAC falling 0.88% and 0.67% apiece. Following was the FTSE, who, having suffered 5% losses by Kingfisher and Johnson Matthey, extended yesterday’s losses, […]

The post Nasdaq dodges the over-extended equities correction appeared first on UK Investor Magazine.

While not moving quite as enthusiastically as they did after previous vaccine updates, Pfizer‘s latest news saw global equities nudge higher on Wednesday. Noticeably muted, though, was the FTSE. Having led the pack in recent vaccine news rallies, the index was weighed the pound rising on renewed Brexit hopes. While the Dow Jones rallied by […]

The post FTSE stunted as pound gains on Brexit hopes appeared first on UK Investor Magazine.

The FTSE was among the biggest index winners on Monday, led by a surge in the previously COVID-stricken equities, as Moderna (NASDAQ:MRNA) announced that its vaccine candidate had a 94.5% efficacy rate. Logistical issues will remain an ongoing concern going forwards. However, the Moderna vaccine doesn’t require the same extreme cold storage as its Pfizer […]

The post Moderna vaccine news sees FTSE soar and value stock recovery continue appeared first on UK Investor Magazine.

After a harsh year for oil traders, in which some blue chip equities hit twenty-year lows, the short-lived enthusiasm for a COVID vaccine has seen oil prices slump once again at the end of the week. Speaking on Thursday, the IEA reiterated the sentiment of other sceptics, saying that, “It is far too early to […]

The post Oil prices fall again with demand not expected to recover until ‘mid-2021’ appeared first on UK Investor Magazine.

Having fallen during the week before last, global equities have since been spurred by the Joe Biden victory and Pfizer vaccine hopes. On Thursday, however, some of the good-feeling steam wore off, as investors greedily priced in potential upsides in the short-term. Choosing to be overly optimistic in the moment, markets are now watching equities […]

The post Global equities ran out of steam as vaccine and Biden jubilation fade appeared first on UK Investor Magazine.

Pfizer’s vaccine announcement saw gold and gilts sell off, while European equities rallied by 5% on Monday. Meanwhile, the tech stocks that boomed during the pandemic – and last week – saw the Nasdaq drop by 1.5% on the same day as Eurozone markets flew. Fast-rising home delivery stocks, Ocado and Just Eat, shed 5.21% […]

The post Have Tech Stocks had their day in the sun? appeared first on UK Investor Magazine.

Having cheered on the news of Pfizer’s (NSYE:PFE) vaccine candidate demonstrating 90% efficacy, global equities heavily priced in COVID challenges being overcome, and favoured pandemic casualties during trading on Tuesday. Leading the charge and at one point up by almost 18%, Lloyds finished up by 6.63%, up to 32.82p a share. Following close behind were […]

The post Global equities chase vaccine hopes: tech falls while oil, finance and airlines rally appeared first on UK Investor Magazine.

Pfizer and BioNTech have announced that their coronavirus vaccine was 90% effective in tests, which has caused global shares to surge. The drug companies have said that the vaccine was “found to be more than 90% effective in preventing Covid-19 in participants without evidence of prior Sars-CoV-2 infection in the first interim efficacy analysis.” The […]

The post Who are the winners & losers on latest Pfizer vaccine news? appeared first on UK Investor Magazine.

AstraZeneca (LON: AZN) has revealed a rise in sales and revenue for the year to date. The pharma giant said in its latest trading update that sales had grown 9% to $18,879m whilst overall revenue had increased 8% compared to the year previously. Pascal Soriot, the chief executive, commented: “We made encouraging headway in the […]

The post AstraZeneca reports rise in sales & revenue appeared first on UK Investor Magazine.

It’s still an election, twenty new COVID policy measures, and a Christmas dinner away, but its worth trying to anticipate what equities will look like as the clock strikes midnight on New Year’s Eve. And, here are three factors to consider. The Christmas COVID Crunch Despite the police commissioner’s misguided tough guy comments about breaking […]

The post Three reasons why New Year’s Eve may be an eventful time for equities appeared first on UK Investor Magazine.

The COVAX Facility is led by the Gavi vaccine alliance group, and has the goal of allowing companies and researchers to collaborate, and develop, produce and provide equitable access to COVID tests, treatments and vaccines. In service of this alliance, UK health giant GSK (LON:GSK) and French pharma blue chip Sanofi (EPA:SAN) have signed a […]

The post GSK and Sanofi sign Statement of Intent to provide 200m COVID vaccines appeared first on UK Investor Magazine.

You’ll likely of heard of the fury stirred up by today’s mutiny, with high-profile Labour MP, Mayor of Greater Manchester and ‘King of the North’, Andy Burnham, refusing to implement Tier 3 restrictions on his home city. Why is he doing it? Well, because he’s probably gauged that a second lockdown won’t be popular in […]

The post Why does ‘King of the North’ Andy Burnham matter? appeared first on UK Investor Magazine.

American multinational medical and pharmaceutical firm Johnson & Johnson (NYSE:JNJ) has seen its shares slip 1.50% on Tuesday afternoon after it announced that its coronavirus vaccine trial has been forced to halt due to the ‘unexplained illness’ of a participant. The company has stated that the volunteer’s illness is currently being assessed by an independent […]

The post Johnson & Johnson shares slide as vaccine trial put on hold appeared first on UK Investor Magazine.

Around the world, pharmaceutical companies and governments are working at record speed to develop a vaccine for the novel coronavirus. There are currently more than 150 potential vaccines in development, with high hopes that an effective product can be introduced to the market within the next year. The demand for a vaccine has increased since […]

The post AstraZeneca and GlaxoSmithKline – the Covid-19 vaccine frontrunners to watch appeared first on UK Investor Magazine.

Shares at Cambridge-based biopharmaceuticals firm AstraZeneca (LON:AZN) have begun a modest rally on Monday as the company resumes its high-stakes coronavirus vaccine trial. Clinical trials of AstraZeneca’s joint venture with Oxford University were forced to halt last week after it emerged that an anonymous participant had suffered from an alleged “adverse reaction”. A New York […]

The post AstraZeneca shares begin rally as Oxford vaccine trial resumes appeared first on UK Investor Magazine.

Shares at Cambridge-based pharmaceutical firm AstraZeneca (LON:AZN) have slipped 1.55% as its coronavirus vaccine trial is put on hold after a participant suffered a suspected adverse reaction. The firm has suspended all clinical trials of its proposed COVID-19 vaccine – which had been in the final stage of human tests – while it routinely reviews […]

The post AstraZeneca shares slip as vaccine trial put on hold appeared first on UK Investor Magazine.

Clinical biotechnology firm Destiny Pharma plc (AIM:DEST) has seen its shares soar by more than 14% after the company announced it has received an £800,000 grant from the country’s leading innovation agency Innovate UK to help develop a novel, preventative treatment for COVID-19. The programme will see Destiny Pharma work alongside London-based biotechnology research company […]

The post Destiny Pharma receives grant for Covid-19 treatment, shares soar appeared first on UK Investor Magazine.

British pharmaceutical company AstraZeneca (LON:AZN) has stated that it will begin producing doses of its potential Coronavirus vaccine, while awaiting the results from its new treatment’s trials. Astrazeneca Chief Executive Pascal Soriot, told BBC Radio 4’s Today programme, “We are starting to manufacture this vaccine right now. “And we have to have it ready to […]

The post AstraZeneca pledges to mass produce potential Coronavirus vaccine appeared first on UK Investor Magazine.

The Dow Jones enjoyed a bright start to the session, rallying 400 points to 24,600 points. This was led by some ‘solid’ earnings, lingering vaccine optimism and hopes of further Fed stimulus in coming weeks, and came despite what many pundits described as the ‘Moderna (NASDAQ:MRNA) shuffle’ – the fluctuating price of the stock since […]

The post Dow Jones keen to rebound after Moderna vaccine doubts appeared first on UK Investor Magazine.